Press Release: LifeMD(R) to Report Third Quarter 2024 Financial Results on November 7

Dow JonesOct 24 08:00 ET

Express News | LifeMD® Launches Testorx, a New Rex Md® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

ReutersOct 23 08:00 ET

LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

GlobeNewswireOct 23 08:00 ET

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

BusinesswireOct 21 16:05 ET

BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsOct 14 14:31 ET · Ratings

LifeMD, Inc.'s (NASDAQ:LFMD) Top Owners Are Retail Investors With 45% Stake, While 38% Is Held by Institutions

Yahoo FinanceOct 12 09:56 ET